Skip to main content

GeneBio, Proxeon Integrate Mass Spec Data Platforms

NEW YORK (GenomeWeb News) – Geneva Bioinformatics and Proxeon have inked an integration and distribution agreement for their respective proteomics and informatics platforms, GeneBio said today.
 
Under the agreement, the companies will integrate GeneBio’s Phenyx protein identification platform with Proxeon’s ProteinCenter data interpretation software. Financial terms of the agreement were not disclosed.
 
The company said the combined offering will enhance efficiency and effectiveness for researchers analyzing mass spectrometry data. Users will link directly between Phenyx identifications to ProteinCenter and specific Phenyx Exports loaded into ProteinCenter, the company said.
 
The Proxeon software is based on a consolidated protein sequence database that enables filtering, protein grouping, and statistical bioinformatics analysis of single, combined, or comparison search results, GeneBio said.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.